Fact CheckerSign in

NCT07698405Recruiting

Effects of Using Advanced NEUROrehabilitation TECHnologies in Upper Limb Motor Function and Capacity Recovery in People With Stroke

Source: ClinicalTrials.gov · Last updated 22 Sept 2026

Brief summary (registry, in English)

This study aims to evaluate the effect of a personalized technology-based rehabilitative intervention on Upper Limb (UL) motor function and capacity recovery in People with Stroke (PwS). The study is single-cohort study in which eligible participants will undergo baseline and follow-up clinical and instrumental assessments over a 4-5 week period. The intervention consists of a personalized and specific upper limb technology-based rehabilitation programme delivered three times per week for a total of 12-15 sessions. Each session lasts approximately one hour and is integrated with conventional rehabilitation treatments. Primary outcomes include Fugl-Meyer Assessment for Upper Extremity (FMA-UE) and Action Research Arm Test (ARAT). Secondary outcomes include instrumental assessment of active range of motion and grip strength.

Status (registry)
Recruiting
Study type
Observational
Enrollment
25 (estimated)
First submitted
7 Jul 2026
Start date
15 Jun 2026
Primary completion date
31 Aug 2027
Lead sponsor
Azienda Unita Sanitaria Locale di Piacenza
Diseases
Stroke
NCT number
NCT07698405

What you commit to

  • Study type: Observational
  • Planned participants: 25
  • From 15 Jun 2026 to the primary completion date, 31 Aug 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Severe and unstable medical conditions (e.g. untreated seizure, heart failure) that preclude participation in rehabilitation;
  • Other neurological and/or psychiatric diseases;

Other

  • Diagnosis of severe aphasia, based on medical records, preventing participation;
  • Bilateral hemisphere lesions;
  • Recent and unstabilized upper limb fracture.

Who the study is looking for

  • Age ≥ 18 years;
  • First-ever unilateral ischemic or hemorrhagic stroke;
  • Presence of upper limb motor impairment;
  • Modified Ashworth Scale (MAS) \< 3;
  • Montreal Cognitive Assessment (MoCA) \> 24;
  • Medically stable and able to participate in an intensive rehabilitation programme;
  • Ability to understand and follow study procedures;
  • Written informed consent.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Fiorenzuola d'Arda Hospital - AUSL Piacenza
Coordinator of this site? Confirm its status
Fiorenzuola d'ArdaItalyRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.